Literature DB >> 7708089

Pulmonary penicillosis marneffei: report of the first imported case in Canada.

A S Sekhon1, L Stein, A K Garg, W A Black, J D Glezos, C Wong.   

Abstract

A 57-year-old female, born in Laos and who had lived in Thailand prior to immigrating to Canada in 1989, was seen by her physician with a chief complaint of cough and dyspnea. Her chest X-ray showed bilateral pulmonary air fluid levels. A fungus, with a diffusible red pigment, tentatively identified as Penicillium marneffei, was isolated from the patient's bronchial washings and sputum specimens. At 37 degrees C, the fungus converted to a yeast form when cultured on brain heart infusion agar. Microscopic examination of this culture revealed yeast cells that reproduced by fission. The identity of the patient's isolate was confirmed as P. marneffei with an exoantigen test. The patient's serum demonstrated specific antibodies to P. marneffei antigen. Treatment with amphotericin B and ketoconazole resulted in clinical improvement, clearing of chest X-rays and conversion to sero-negativity. Our case is the first recorded diagnosis of imported penicillosis marneffei in Canada. The minimal inhibitory concentrations recorded for the patient's isolate to fluconazole, 5-fluorocytosine, itraconazole and miconazole were 12.5, 0.39, < 0.195 and < 0.195 micrograms/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7708089     DOI: 10.1007/bf01104271

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  14 in total

1.  [Penicillium marneffei n.sp., agent of a mycosis of the reticuloendothelial system].

Authors:  G SEGRETAIN
Journal:  Mycopathol Mycol Appl       Date:  1959-11-30

2.  Penicillium marneffei infection in an AIDS patient.

Authors:  C M Hulshof; R A van Zanten; J F Sluiters; M E van der Ende; R S Samson; P E Zondervan; J H Wagenvoort
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

3.  Penicillium marneffei infection: a follow-up.

Authors:  A F DiSalvo
Journal:  Am J Clin Pathol       Date:  1989-04       Impact factor: 2.493

4.  Infection caused by Penicillium marneffei: description of first natural infection in man.

Authors:  A F DiSalvo; A M Fickling; L Ajello
Journal:  Am J Clin Pathol       Date:  1973-08       Impact factor: 2.493

5.  In vitro growth inhibitory studies of phacidin against some dermatophytes, opportunistic and systemic fungi, and yeasts pathogenic on man.

Authors:  A S Sekhon; A Funk
Journal:  J Antimicrob Chemother       Date:  1977-01       Impact factor: 5.790

6.  Penicillosis marneffei: serological and exoantigen studies.

Authors:  A S Sekhon; J S Li; A K Garg
Journal:  Mycopathologia       Date:  1982-01-15       Impact factor: 2.574

7.  In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.

Authors:  A S Sekhon; A K Garg; A A Padhye; Z Hamir
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

8.  Effect of culture media on in vitro susceptibility testing of fluconazole against some yeasts.

Authors:  A S Sekhon; A K Garg; Z Hamir
Journal:  Mycoses       Date:  1991 Jul-Aug       Impact factor: 4.377

9.  Treatment and serological studies of an Italian case of penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus.

Authors:  M A Viviani; A M Tortorano; G Rizzardini; T Quirino; L Kaufman; A A Padhye; L Ajello
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

10.  In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.

Authors:  A S Sekhon; A A Padhye; A K Garg
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

View more
  9 in total

Review 1.  Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.

Authors:  Cunwei Cao; Liyan Xi; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

2.  Sixty Years from Segretain's Description: What Have We Learned and Should Learn About the Basic Mycology of Talaromyces marneffei?

Authors:  Chi-Ching Tsang; Susanna K P Lau; Patrick C Y Woo
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

3.  In Vitro Activity of Posaconazole against Talaromyces marneffei by Broth Microdilution and Etest Methods and Comparison to Itraconazole, Voriconazole, and Anidulafungin.

Authors:  Susanna K P Lau; George C S Lo; Clare S K Lam; Wang-Ngai Chow; Antonio H Y Ngan; Alan K L Wu; Dominic N C Tsang; Cindy W S Tse; Tak-Lun Que; Bone S F Tang; Patrick C Y Woo
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

4.  Usefulness of a microimmunodiffusion test for the detection of Penicillium marneffei antigenemia, antibodies, and exoantigens.

Authors:  P Imwidthaya; A S Sekhon; T D Mastro; A K Garg; E Ambrosie
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

5.  Different susceptibilities of yeasts and conidia of Penicillium marneffei to nitric oxide (NO)-mediated fungicidal activity of murine macrophages.

Authors:  N Kudeken; K Kawakami; A Saito
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

6.  Identification of microRNA-like RNAs in mycelial and yeast phases of the thermal dimorphic fungus Penicillium marneffei.

Authors:  Susanna K P Lau; Wang-Ngai Chow; Annette Y P Wong; Julian M Y Yeung; Jessie Bao; Na Zhang; Si Lok; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  PLoS Negl Trop Dis       Date:  2013-08-22

7.  Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for rapid identification of mold and yeast cultures of Penicillium marneffei.

Authors:  Susanna K P Lau; Clare S K Lam; Antonio H Y Ngan; Wang-Ngai Chow; Alan K L Wu; Dominic N C Tsang; Cindy W S Tse; Tak-Lun Que; Bone S F Tang; Patrick C Y Woo
Journal:  BMC Microbiol       Date:  2016-03-10       Impact factor: 3.605

8.  Novel Partitivirus Enhances Virulence of and Causes Aberrant Gene Expression in Talaromyces marneffei.

Authors:  Susanna K P Lau; George C S Lo; Kwok-Yung Yuen; Franklin W N Chow; Rachel Y Y Fan; James J Cai; Patrick C Y Woo
Journal:  MBio       Date:  2018-06-12       Impact factor: 7.867

Review 9.  Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis.

Authors:  Shanti Narayanasamy; John Dougherty; H Rogier van Doorn; Thuy Le
Journal:  Mycopathologia       Date:  2021-07-06       Impact factor: 2.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.